StockData
DRUGNasdaqPharmaceutical PreparationsFiscal year ends September 30

BRIGHT MINDS BIOSCIENCES INC.

Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 40-F on Dec 23, 2025
$53.82+2.52 (+4.91%)

Close on Oct 19, 2026

Bright Minds Biosciences statistics

Financials through Sep 30, 2025, price-based ratios appear once a share price is available, median of Pharmaceutical Preparations companies for comparison

Valuation

MeasureBright Minds BiosciencesIndustry median
Market CapC$586.40MC$123.83M
Enterprise ValueC$503.49MC$93.80M

Balance sheet

MeasureBright Minds BiosciencesIndustry median
Cash & Short-Term InvestmentsC$82.91MC$27.83M
Net Cash (Debt)C$82.91MC$27.83M
Net Cash Per Share10.86 CAD0.25 CAD
Working CapitalC$81.97MC$25.22M

Financial position

MeasureBright Minds BiosciencesIndustry median
Current Ratio36.102.65
Quick Ratio35.501.40

Cash flow (trailing twelve months)

MeasureBright Minds BiosciencesIndustry median
Operating Cash Flow-C$8.69M-C$8.69M

Efficiency

MeasureBright Minds BiosciencesIndustry median
Employee Count126

Dividends and yields

MeasureBright Minds BiosciencesIndustry median
Buyback Yield-14.0%-9.44%
Shareholder Yield-14.0%-9.44%

Shares

MeasureBright Minds BiosciencesIndustry median
Shares Outstanding7,635,79074,643,400
Shares Change (YoY)59.6%18.0%
Float6,239,12074,292,200
Shares Held by Insiders18.3%0.00%
Shares Held by Institutions121.9%9.14%

Taxes

MeasureBright Minds BiosciencesIndustry median
Income TaxC$0C$0

Scores

MeasureBright Minds BiosciencesIndustry median
Altman Z-Score148.43-0.68

Calculated by StockData from Bright Minds Biosciences's SEC filings. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.